Juniper Pharmaceuticals Company Profile (NASDAQ:JNP)

About Juniper Pharmaceuticals

Juniper Pharmaceuticals logoJuniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a women's health therapeutic company focused on developing intra-vaginal therapeutics that addresses the medical needs in women's health. The Company operates through two segments: product and service. The product segment includes supply chain management for CRINONE. The product segment also includes the royalty stream the Company receives from Allergan for CRINONE sales in the United States, as well as the development of new product candidates. The service segment includes pharmaceutical development, clinical trial manufacturing and advanced analytical and consulting services for the its customers, as well as characterizing and developing pharmaceutical product candidates for its internal programs, and managing the preclinical and clinical manufacturing of COL-1077 and its intra-vaginal ring (IVR). Its product and product development programs include CRINONE 8%, COL-1077, JNP-0101, JNP-0101 and JNP-0301.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: JNP
  • CUSIP:
Key Metrics:
  • Previous Close: $4.80
  • 50 Day Moving Average: $5.19
  • 200 Day Moving Average: $5.57
  • 52-Week Range: $4.30 - $8.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -48.00
  • P/E Growth: 0.00
  • Market Cap: $52.05M
  • Outstanding Shares: 10,843,000
  • Beta: 0.25
Profitability:
  • Net Margins: -7.44%
  • Return on Equity: -9.68%
  • Return on Assets: -6.47%
Debt:
  • Debt-to-Equity Ratio: 0.08%
  • Current Ratio: 1.73%
  • Quick Ratio: 1.42%
Additional Links:
Companies Related to Juniper Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Juniper Pharmaceuticals (NASDAQ:JNP) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $11.63 (142.19% upside)

Analysts' Ratings History for Juniper Pharmaceuticals (NASDAQ:JNP)
Show:
DateFirmActionRatingPrice TargetDetails
8/21/2016Roth CapitalSet Price TargetBuy$16.50View Rating Details
8/19/2016HC WainwrightDowngradeBuy -> Neutral$6.75View Rating Details
8/18/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Juniper Pharmaceuticals (NASDAQ:JNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2017        
11/15/2016Q3 2016($0.15)$0.02$11.60 millionViewN/AView Earnings Details
5/4/2016Q116($0.08)$0.03$9.13 million$12.10 millionViewN/AView Earnings Details
3/10/2016Q415($0.02)($0.19)$7.89 million$7.60 millionViewN/AView Earnings Details
11/10/2015Q315($0.05)$0.09$7.10 million$11.50 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.03)$8.35 million$10.20 millionViewN/AView Earnings Details
5/6/2015Q115$0.04$0.07$7.80 million$8.30 millionViewN/AView Earnings Details
3/18/2015Q414$0.07($0.05)$7.93 million$7.30 millionViewN/AView Earnings Details
10/28/2014Q314$0.12$0.34$9.74 million$11.50 millionViewN/AView Earnings Details
7/31/2014Q2$0.11$0.01ViewN/AView Earnings Details
4/29/2014Q114$0.07$0.01$6.30 million$7.20 millionViewN/AView Earnings Details
3/5/2014Q413$0.08$7.10 million$7.80 millionViewN/AView Earnings Details
11/7/2013Q313$0.16$0.20$6.75 million$7.10 millionViewN/AView Earnings Details
8/7/2013Q2 2013$0.02$0.03$6.50 million$7.02 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.03$0.01$6.50 million$6.30 millionViewN/AView Earnings Details
3/14/2013Q4 2012$0.02$0.03$7.60 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Juniper Pharmaceuticals (NASDAQ:JNP)
Current Year EPS Consensus Estimate: $0.23 EPS
Next Year EPS Consensus Estimate: $-0.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.11$0.11$0.11
Q2 20161$0.10$0.10$0.10
Q3 20161$0.12$0.12$0.12
Q4 20161$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Juniper Pharmaceuticals (NASDAQ:JNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Juniper Pharmaceuticals (NASDAQ:JNP)
Insider Ownership Percentage: 11.60%
Institutional Ownership Percentage: 33.12%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016James A GeraghtyDirectorBuy2,000$5.97$11,940.00View SEC Filing  
8/31/2016George ElstonCFOBuy1,000$5.50$5,500.00View SEC Filing  
8/26/2016C Ann MerrifieldDirectorBuy2,000$5.63$11,260.00View SEC Filing  
8/25/2016Alicia SecorInsiderBuy5,000$5.75$28,750.00View SEC Filing  
8/23/2016James A GeraghtyDirectorBuy7,000$5.96$41,720.00View SEC Filing  
12/4/2015C Ann MerrifieldDirectorBuy1,600$12.14$19,424.00View SEC Filing  
11/19/2015Nikin PatelCOOBuy5,000$11.82$59,100.00View SEC Filing  
11/18/2015Frank Condella JrCEOBuy5,000$11.68$58,400.00View SEC Filing  
8/14/2015C Ann MerrifieldDirectorBuy3,000$9.90$29,700.00View SEC Filing  
6/15/2015Frank M ArmstrongDirectorBuy1,255$7.95$9,977.25View SEC Filing  
6/9/2015Nikin PatelCOOBuy13,500$7.52$101,520.00View SEC Filing  
5/8/2015Frank Condella JrCEOBuy10,000$7.36$73,600.00View SEC Filing  
11/20/2014Donald H HunterDirectorBuy1,000$5.98$5,980.00View SEC Filing  
8/13/2014Frank Condella JrCEOBuy10,000$5.98$59,800.00View SEC Filing  
5/5/2014Frank Condella JrCEOBuy10,000$6.65$66,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Juniper Pharmaceuticals (NASDAQ:JNP)
DateHeadline
News IconSell-side analyst take on Juno Therapeutics, Inc. (NASDAQ:JUNO) Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Sherwood Daily (NASDAQ:JNP)
sherwooddaily.com - February 22 at 6:17 PM
News IconJuniper Pharmaceuticals Inc JNP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:JNP)
www.bioportfolio.com - February 22 at 12:30 PM
News IconStock Focus: Juniper Pharmaceuticals Inc (NASDAQ:JNP) Price Target Update - Rockville Register (NASDAQ:JNP)
rockvilleregister.com - February 20 at 5:30 PM
News IconStreet Target Update on Juniper Pharmaceuticals Inc (NASDAQ:JNP) - Rockville Register (NASDAQ:JNP)
rockvilleregister.com - February 18 at 12:10 PM
marketwatch.com logoLatest version of Dodd-Frank reversal bill would exempt a third of public companies from giving auditor warning (NASDAQ:JNP)
www.marketwatch.com - February 16 at 5:45 PM
News IconTrading Corner: Eye on Technical Levels for Juniper Pharmaceuticals Inc. (JNP) - Providence Standard (NASDAQ:JNP)
providencestandard.com - February 8 at 6:50 PM
News IconTrading Sheet: Tracking Technicals for Juniper Pharmaceuticals Inc. (JNP) - Sherwood Daily (NASDAQ:JNP)
sherwooddaily.com - February 4 at 4:45 AM
News IconTrading Radar: Checking Technicals for Juniper Pharmaceuticals Inc. (JNP) - Sherwood Daily (NASDAQ:JNP)
sherwooddaily.com - February 2 at 11:53 PM
News IconCan This Stock Gain Traction: Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Prospect Journal (NASDAQ:JNP)
prospectjournal.com - January 30 at 11:47 PM
News IconWhat is the Street Saying About Juniper Pharmaceuticals Inc (NASDAQ:JNP)? - Aiken Advocate (NASDAQ:JNP)
aikenadvocate.com - January 29 at 6:24 PM
finance.yahoo.com logoJuniper Pharmaceuticals Presents Poster at SMFM 2017 on Current Practice Among U.S. Obstetricians to Screen, Define, and Treat a Short Cervix to Prevent Preterm Birth (NASDAQ:JNP)
finance.yahoo.com - January 26 at 7:49 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Juniper Pharmaceuticals Inc (NASDAQ:JNP) - Aiken Advocate (NASDAQ:JNP)
aikenadvocate.com - January 20 at 9:19 PM
News IconEquity Insight: Indicator Review for Juniper Pharmaceuticals Inc. (JNP) - Sherwood Daily (NASDAQ:JNP)
sherwooddaily.com - January 17 at 6:27 PM
News IconAre There Catalysts to Propel This Stock Forward: Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Prospect Journal (NASDAQ:JNP)
prospectjournal.com - January 9 at 11:50 PM
finance.yahoo.com logoJuniper Pharmaceuticals Unveils Strategic and Product Development Objectives for 2017 - Yahoo Finance (NASDAQ:JNP)
finance.yahoo.com - January 7 at 4:46 AM
reuters.com logoBRIEF-Juniper Pharma will focus on IND-enabling activities for JNP-0201 (NASDAQ:JNP)
www.reuters.com - January 6 at 6:46 PM
us.rd.yahoo.com logo8:01 am Juniper Pharma announced plans for 2017 that are expected to enable the Company to submit Investigational New Drug applications for its hormone-delivery intravaginal ring candidates in the first half of 2018 (NASDAQ:JNP)
us.rd.yahoo.com - January 6 at 6:45 PM
publicnow.com logoJuniper Pharmaceuticals Unveils Strategic and Product Development Objectives for 2017 (NASDAQ:JNP)
www.publicnow.com - January 6 at 6:45 PM
reuters.com logoBRIEF-Juniper Pharmaceuticals prototype formulation development for JNP-0301 is underway (NASDAQ:JNP)
www.reuters.com - January 5 at 7:22 PM
News IconValue Score Review for Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Wall Street Beacon (NASDAQ:JNP)
wsbeacon.com - January 4 at 2:30 AM
News IconUpside Alert: Delving into Shares of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Prospect Journal (NASDAQ:JNP)
prospectjournal.com - January 3 at 11:26 AM
4-traders.com logoJUNIPER PHARMACEUTICALS INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:JNP)
www.4-traders.com - December 23 at 6:19 PM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, (NASDAQ:JNP)
biz.yahoo.com - December 23 at 6:19 PM
prnewswire.com logoJuniper Pharmaceuticals Announces Appointment of Jeffrey Young as Chief Financial Officer - PR Newswire (press release) (NASDAQ:JNP)
www.prnewswire.com - December 21 at 8:20 AM
finance.yahoo.com logo8:01 am Juniper Pharma appoints Jeffrey Young to succeed George Elston as CFO effective Jan 1, 2017 (NASDAQ:JNP)
finance.yahoo.com - December 20 at 11:38 AM
publicnow.com logoJuniper Pharmaceuticals Announces Appointment of Jeffrey Young as Chief Financial Officer (NASDAQ:JNP)
www.publicnow.com - December 20 at 11:38 AM
News IconValue Score Review for Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Highland Digest (NASDAQ:JNP)
highlanddigest.com - December 18 at 11:12 PM
News IconInvestor Hub: Looking at Shares of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Business Daily Leader (NASDAQ:JNP)
businessdailyleader.com - December 16 at 4:45 AM
News IconTechnical Trading: Focus on Shares of Juniper Pharmaceuticals Inc. (JNP) - Yankee Analysts (NASDAQ:JNP)
yankeeanalysts.com - December 13 at 11:32 PM
News IconEnterprise Value Review for Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Liberty News (NASDAQ:JNP)
libertynewsrecord.com - December 13 at 6:32 PM
News IconMarket Focus: Zooming in on Shares of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - OIB News (NASDAQ:JNP)
oibnews.com - December 13 at 10:09 AM
sbwire.com logoNetwork Security Market: Global Industry Analysis and Forecast 2016 - 2026 (NASDAQ:JNP)
www.sbwire.com - December 8 at 6:39 PM
sbwire.com logoNetwork as a Service Market Explores New Growth Opportunities During 2016-2026 (NASDAQ:JNP)
www.sbwire.com - December 8 at 10:24 AM
News IconValue Score Review for Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - OIB News (NASDAQ:JNP)
oibnews.com - December 7 at 6:10 PM
News IconInvestor Focus: Watching Shares of Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - OIB News (NASDAQ:JNP)
oibnews.com - November 30 at 9:46 AM
News IconWatching the Technicals on Shares of Juniper Pharmaceuticals Inc. (JNP) - Yankee Analysts (NASDAQ:JNP)
yankeeanalysts.com - November 30 at 9:46 AM
capitalcube.com logoJuniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 (NASDAQ:JNP)
www.capitalcube.com - November 29 at 4:23 PM
capitalcube.com logoJuniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016 (NASDAQ:JNP)
www.capitalcube.com - November 29 at 4:23 PM
News IconLooking at the Gauges on Juniper Pharmaceuticals Inc. (JNP) - Yankee Analysts (NASDAQ:JNP)
yankeeanalysts.com - November 24 at 8:56 AM
News IconUpdate on Valuation Formula's For Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Wall Street Lion (NASDAQ:JNP)
wslnews.com - November 23 at 8:39 AM
News IconChart Watch: Following Indicators on Shares of Juniper Pharmaceuticals Inc. (JNP) - MicroCap Wired (NASDAQ:JNP)
www.microcapwired.com - November 22 at 5:48 PM
News IconWilliams %R Check on Shares of Juniper Pharmaceuticals Inc. (JNP) - MicroCap Wired (NASDAQ:JNP)
www.microcapwired.com - November 22 at 9:46 AM
News IconJuniper Pharmaceuticals, Inc. JNP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:JNP)
www.bioportfolio.com - November 19 at 5:52 PM
finance.yahoo.com logoJUNIPER PHARMACEUTICALS INC Financials (NASDAQ:JNP)
finance.yahoo.com - November 19 at 5:52 PM
News IconWhat is the Street Saying About Juniper Pharmaceuticals Inc (NASDAQ:JNP)? - CSZ News (NASDAQ:JNP)
cincysportszone.com - November 19 at 8:20 AM
News IconTechnical Updates for Juniper Pharmaceuticals Inc. (JNP) - MicroCap Wired (NASDAQ:JNP)
www.microcapwired.com - November 18 at 8:23 AM
seekingalpha.com logoJuniper Pharmaceuticals' (JNP) CEO Alicia Secor on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:JNP)
seekingalpha.com - November 17 at 5:23 PM
News IconStock Watch: Indicators in View for Juniper Pharmaceuticals Inc. (JNP) - Yankee Analysts (NASDAQ:JNP)
yankeeanalysts.com - November 16 at 6:00 PM
News IconWhat The Charts Are Saying About Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Wall Street Lion (NASDAQ:JNP)
wslnews.com - November 16 at 6:00 PM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, (NASDAQ:JNP)
biz.yahoo.com - November 16 at 6:00 PM

Social

What is Juniper Pharmaceuticals' stock symbol?

Juniper Pharmaceuticals trades on the NASDAQ under the ticker symbol "JNP."

Where is Juniper Pharmaceuticals' stock going? Where will Juniper Pharmaceuticals' stock price be in 2017?

3 brokers have issued twelve-month target prices for Juniper Pharmaceuticals' shares. Their forecasts range from $6.75 to $16.50. On average, they anticipate Juniper Pharmaceuticals' stock price to reach $11.63 in the next year.

When will Juniper Pharmaceuticals announce their earnings?

Juniper Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.

Who owns Juniper Pharmaceuticals stock?

Juniper Pharmaceuticals' stock is owned by a number of of retail and institutional investors. Top institutional investors include JW Asset Management LLC (3.03%), Renaissance Technologies LLC (2.35%), Stonepine Capital Management LLC (2.11%), Dimensional Fund Advisors LP (0.66%), Gabelli Funds LLC (0.60%) and GSA Capital Partners LLP (0.19%). Company insiders that own Juniper Pharmaceuticals stock include Alicia Secor, C Ann Merrifield, Frank Condella Jr, Frank M Armstrong, George Elston, James A Geraghty and Nikin Patel.

Who sold Juniper Pharmaceuticals stock? Who is selling Juniper Pharmaceuticals stock?

Juniper Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP.

Who bought Juniper Pharmaceuticals stock? Who is buying Juniper Pharmaceuticals stock?

Juniper Pharmaceuticals' stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Renaissance Technologies LLC and JW Asset Management LLC. Company insiders that have bought Juniper Pharmaceuticals stock in the last two years include Alicia Secor, C Ann Merrifield, Frank Condella Jr, Frank M Armstrong, George Elston, James A Geraghty and Nikin Patel.

How do I buy Juniper Pharmaceuticals stock?

Shares of Juniper Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Juniper Pharmaceuticals stock cost?

One share of Juniper Pharmaceuticals stock can currently be purchased for approximately $4.80.

Juniper Pharmaceuticals (NASDAQ:JNP) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Juniper Pharmaceuticals (NASDAQ:JNP)

Earnings History Chart

Earnings by Quarter for Juniper Pharmaceuticals (NASDAQ:JNP)

Dividend History Chart

Dividend Payments by Quarter for Juniper Pharmaceuticals (NASDAQ:JNP)

Last Updated on 2/23/2017 by MarketBeat.com Staff